Designed to engage academic scientists, pharma open innovation groups, infrastructure providers, CROs and funders from across Europe, the SLAS Translating Research Ideas into Future Therapeutics Conference enables the progression through discovery pipelines of novel therapeutic innovations from academia and small companies.
Project holders Scientists with new ideas or already established assets in the areas of small molecule, biologicals and enabling technologies approaches, are all welcome. The conference presents a rare opportunity to talk to about progress, learn from the experiences of colleagues and potentially build new alliances and thereby create future development partnerships.
Who should attend ?
Scientists (Project Holders) and Technology Transfer professionals; from Universities, Not for Profit, Applied Research institutes and Academic spin-outs/SMEs
Venture Capital Organisations, Pharma Open Innovation staff, employees and board members of Government and funding organisations
Providers of Infrastructure and services
The organising committee of this meeting is gearing up for an exciting and comprehensive Conference programme including:
“This exciting meeting in Belgium, the heart of Europe, will be the ideal forum for disease area specialists from academia and biotech to showcase their projects to the Pharma Industry, VC, CRO’s and public funders. We encourage our colleagues from academia and innovative biotech companies to take this opportunity to start your journey out of the Valley of Death, and come and meet your peers and the expert drug discovery professionals who will be assembled in Leuven at SLAS Translating Research Ideas into Future Therapeutics Conference, 2016.”
“This is an opportunity for European scientists wanting to explore ways of taking their projects further down the development pipeline. The meeting is for all those involved in early stage translational research, not just project holders, but those that can facilitate the process in terms of supplying, expertise, capability, access to funding and routes through to potential partnering. The meeting will build on and extend the SLAS Europe network of life science research and development professionals. It’s a chance for scientists to talk to scientists about “what next for my project?”
The Conference will bring academic scientists and start-ups together with Pharma Open Innovation groups, infrastructure providers, CROs and public funding bodies from across Europe. Project presentations and poster abstracts are welcome from across the complete range of potential therapeutic modalities including small molecules, biologicals, regenerative medicine, digital technologies and devices etc.
In front of an audience of VC’s, Pharma Open Innovation groups and government funding organisations, project holders from academia and start-ups will have an opportunity to:
Deadline for submission is 30 October. The results of the selection of projects will be announced via email.
Posters can only be submitted via the official SLAS Poster Submission Template and returned to the SLAS Europe Office at firstname.lastname@example.org.
Posters will be presented during the Poster Viewing Tour and evaluated by the independent scientific committee onsite, where the winner will be selected and awarded. If the poster meets sufficient quality requirements, the winner will get the chance to present at SLAS2017 in Washington, DC.
Please review the submission guidelines before sending the abstract. We look forward to receiving your contribution!
Deadline for submission is 30 October. The results of the selection of poster abstracts will be announced via email.
In addition to oral presentations and poster sessions, there will be an exciting programme of poster sessions, networking events and the opportunity for one-to-one meetings.
Lively Leuven is an architectural jewel, Belgium’s reigning brewing capital and Flanders’ oldest university town. The picturesque core is home to one of the best-known Gothic town halls worldwide and Leuven's pride and joy.
For more information please visit www.leuven.be